Managers
A new fund that aims to invest in EIS-qualifying companies in the media and entertainment industries has been launched by Atlantic Screen Media Limited. Atlantic is seeking to raise GBP15m in the current tax year for identified projects.
Demand for content in film and television worldwide is growing exponentially as consumers move to watching TV and film on their mobile devices in increasing numbers. Streaming video devices and smartphones are fast becoming the channel of choice for both old and new generations of customers. This, added to the range of delivery mediums such as Netflix, Amazon, Hulu and all the
Arrowroot Capital Management has held the closing of its third fund, Arrowroot Capital III with over USD177 million in limited partner and general partner commitments.
The fund was oversubscribed and closed at its fundraising cap. The firm has already completed a number of investments throughout 2017 and expects to close additional opportunities prior to the end of the year.
Founder & Managing Partner, Matthew Safaii, says: “We are pleased to have brought in an impressive core of leading endowments, foundations, consultants, pensions, alternative asset managers, and other institutions who we look forward to working with in the months and
Aster has raised an additional EUR240 million bringing its total funds under management to EUR500 million. A specialist in digital transformation and industries of the future, the investment company provides support to growing companies in the sectors of energy, mobility and industry.
Building from a Business Hub, a true acceleration platform serving entrepreneurs, Aster provides them with support to jump-start their development projects and benefit from corporate investor networks.
A EUR240 million capital increase is to be invested primarily in Europe and the United States. The EUR240 million in capital raised in the first closing by several industrial players
Medigold Health, a provider of occupational health and corporate wellbeing services, has received a GBP9.5 million investment from the Business Growth Fund (BGF) to support its ambitious growth plans.
The Northampton-based business has used some of the funds to make two strategic acquisitions, buying IMASS, an occupational health provider with a focus in the South West of England and on public sector customers, and Hampton Knight, a specialist provider of alcohol and drug screening services throughout the UK.
Founded 20 years ago by Dr Mike Goldsmith, and now under the leadership of his son Alex Goldsmith, Medigold Health provides
Five Capital, a subsidiary of CDC International Capital based in Dubai and Riyadh, has entered into exclusive negotiations with Diwanee, a subsidiary of Webedia Group, French specialist in theme-based online publishing, for a merger between Diwanee and Uturn Entertainment, a Saudi digital content provider.
Further discussions between the parties will take place in the coming weeks with a view to concluding a final agreement. This transaction, if agreed, will be subject to board approval from each concerned party and would be undertaken in full compliance with current local and international laws and regulations.
Based in Jeddah, the company Uturn
Intermediate Capital Group (ICG) has raised EUR5.2 billion for Senior Debt Partners III (SDP3), the largest pooled direct lending fund in Europe so far in 2017.
The SDP3 transaction took from January to September 2017 to structure, document and close. The fund was oversubscribed and catered for a wide-range of investors, including a large number of pension fund and insurers.
Investors were global, located in a large number of jurisdictions such as Israel, Korea, Australia, the US and Europe. Consequently, the structure had to be flexible enough to cater for a wide-range of international regulatory and tax requirements. There
Pure Harvest Smart Farms (Pure Harvest), a tech-enabled arid climate agribusiness based in Abu Dhabi in the United Arab Emirates, has secured seed investment of USD4.5 million in a financing round that was significantly oversubscribed.
This follows an earlier USD1.1 million pre-seed round led by Abu Dhabi-based Shorooq Investments.
Venture financing was provided by a leading federal government-backed fund, the Company’s technology partners, and a consortium of Angel investors from around the world, all of whom were strongly aligned with the Company’s mission – to offer a true & tangible food security solution to the region by deploying advanced
Trilantic Europe, a private equity firm focused on mid-market transactions in Europe, has acquired Oberberg Group, an operator of psychotherapy, psychiatry and psychosomatic acute clinics in Germany, with a focus on treatments for depression and addictions.
The transaction allows Trilantic Europe to invest in a leading and specialised healthcare operator in the German private psychotherapy market based on an attractive portfolio of clinics and a unique therapy concept.
Oberberg Group operates nine clinics at eight locations with approximately 560 beds focused on privately insured patients. The clinics operate under different brands including Oberberg Kliniken, SOMNIA Privatkliniken, Rhein-Jura Klinik and
Alter Domus, a provider of fund and corporate services to alternative investment managers, is to acquire Cortland Capital Markets Services (Cortland) in the US. The terms of the transaction have not been disclosed.
Headquartered in Chicago and with offices in New York, London, Los Angeles, Austin, Indianapolis, and China, Cortland is a leading independent investment servicing company providing third – party fund administration and middle and back – office outsourcing to financial institutions, including alternative investment managers, real estate private equity firms and cred it funds. It currently has over USD180 billion of assets under administration. The firm was founded
Sixth Element Capital (6EC), a UK based fund manager established to manage investments for the GBP70 million CRT Pioneer Fund, has made a GBP3 million investment in NeoPhore Ltd, a spin out from Cambridge, UK based PhoreMost Ltd.
NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. The investment will be used to build on the discoveries already made by PhoreMost and its collaborators. NeoPhore’s drug target rationale is highly validated by genetic evidence in cancer patients and cellular models.
NeoPhore aims to exploit novel biological
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
